Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone TherapyHot Flashes, Pathological Conditions, Signs and Symptoms, Signs and SymptomsActive, not recruitingPhase 32026-09-22NCT06440967

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Astellas Pharma Global Development, Inc.43

110 results · Page 1 of 5

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Site CA15001QuébecCanada1
Site CA15002MontrealCanada1
Site CA15003SherbrookeCanada1
Site CA15004QuébecCanada1
Site CA15007Trois-RivièresCanada1
Site CA15016Sault Ste. MarieCanada1
Site CA15019SarniaCanada1
Site CA15020VictoriavilleCanada1
Site CZ42001OlomoucCzechia1
Site CZ42002Hradec KrálovéCzechia1
Site CZ42003HořoviceCzechia1
Site CZ42004TáborCzechia1
Site CZ42005PragueCzechia1
Site CZ42006České BudějoviceCzechia1
Site CZ42007VodňanyCzechia1
Site CZ42008PragueCzechia1
Site CZ42009VsetínCzechia1
Site CZ42011Nový JičínCzechia1
Site CZ42013PragueCzechia1
Site DE45003EsbjergDenmark1
Site DE45008SønderborgDenmark1
Site DE49001BottropGermany1
Site DE49007MönchengladbachGermany1
Site DE49009LeipzigGermany1
Site DE49010MünchenGermany1